pX330.puro Citations (1)

Originally described in: HuR (ELAVL1) silencing sensitizes triple-negative breast cancer to glutaminase-targeted therapy
Sandra Martha Gomes Dias Unpublished

Articles Citing pX330.puro

Articles
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients. Qiao X, van der Zanden SY, Li X, Tan M, Zhang Y, Song JY, van Gelder MA, Hamoen FL, Janssen L, Zuur CL, Pang B, van Tellingen O, Li J, Neefjes J. Mol Cancer. 2024 Jun 4;23(1):120. doi: 10.1186/s12943-024-02034-7. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.